• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Deceleration in the rate of keratinocyte cancers and precancerous lesions during programmed death-1 inhibition therapy for advanced melanoma, with recrudescence on discontinuation.

作者信息

Roche L, Moriarty B, Fabre A, Crowne J, Lally A

机构信息

Departments of Dermatology,, St Vincent's Healthcare Group Strategic Skin Cancer Network, St Vincent's University Hospital, Dublin, Ireland.

Histopathology, St Vincent's Healthcare Group Strategic Skin Cancer Network, St Vincent's University Hospital, Dublin, Ireland.

出版信息

Clin Exp Dermatol. 2022 Mar;47(3):582-584. doi: 10.1111/ced.14974. Epub 2021 Dec 28.

DOI:10.1111/ced.14974
PMID:34633688
Abstract
摘要

相似文献

1
Deceleration in the rate of keratinocyte cancers and precancerous lesions during programmed death-1 inhibition therapy for advanced melanoma, with recrudescence on discontinuation.在晚期黑色素瘤程序性死亡-1抑制治疗期间，角质形成细胞癌和癌前病变的发生率下降，停药后复发。
Clin Exp Dermatol. 2022 Mar;47(3):582-584. doi: 10.1111/ced.14974. Epub 2021 Dec 28.
2
Resistance to PD-1 blockade in melanoma.黑色素瘤对PD-1阻断的耐药性。
Lancet Oncol. 2016 Sep;17(9):e376. doi: 10.1016/S1470-2045(16)30372-2. Epub 2016 Jul 22.
3
Unresectable Non-metastatic Primary Melanoma: Complete Remission Following Treatment with Anti-Programmed-cell-death-receptor 1.不可切除的非转移性原发性黑色素瘤：抗程序性细胞死亡受体1治疗后完全缓解
Acta Derm Venereol. 2019 Jan 1;99(1):107-108. doi: 10.2340/00015555-3028.
4
PD-1 blockade in patients with advanced cutaneous squamous-cell carcinoma and concurrent chronic lymphocytic leukaemia : a case series and literature review.晚期皮肤鳞状细胞癌合并慢性淋巴细胞白血病患者的程序性死亡受体1阻断治疗：病例系列及文献综述
Eur J Dermatol. 2020 Feb 1;30(1):69-71. doi: 10.1684/ejd.2020.3710.
5
Vitiligo under anti-programmed cell death-1 therapy is associated with increased survival in melanoma patients.抗程序性细胞死亡-1治疗下的白癜风与黑色素瘤患者生存率提高相关。
J Am Acad Dermatol. 2020 Mar;82(3):770-772. doi: 10.1016/j.jaad.2019.11.017. Epub 2019 Nov 14.
6
Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma.程序性细胞死亡蛋白1抑制剂治疗皮肤鳞状细胞癌的随访
JAMA Dermatol. 2017 Jan 1;153(1):92-94. doi: 10.1001/jamadermatol.2016.3884.
7
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810.抗 PD-1 单克隆抗体 REGN2810 对转移性基底细胞癌和皮肤鳞状细胞癌的疗效。
J Immunother Cancer. 2016 Nov 15;4:70. doi: 10.1186/s40425-016-0176-3. eCollection 2016.
8
Persistence of superficial basal cell carcinoma during pembrolizumab treatment for metastatic melanoma.帕博利珠单抗治疗转移性黑色素瘤期间浅表基底细胞癌持续存在。
Eur J Dermatol. 2021 Feb 1;31(1):99-100. doi: 10.1684/ejd.2020.3958.
9
Focal regression of a primary melanoma, fading lentigines and poliosis in metastatic melanoma treated with anti-PD-1.原发性黑色素瘤的局灶性消退、消退性雀斑样痣及抗PD-1治疗转移性黑色素瘤时出现的白发症
J Eur Acad Dermatol Venereol. 2018 May;32(5):e176-e177. doi: 10.1111/jdv.14678. Epub 2017 Dec 1.
10
Common skin cancers.常见皮肤癌。
Minn Med. 2004 Mar;87(3):44-7.

引用本文的文献

1
Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response.非黑色素瘤皮肤癌患者中免疫治疗候选者的识别：反应潜在预测因素综述
J Clin Med. 2022 Jun 11;11(12):3364. doi: 10.3390/jcm11123364.